Fosun Pharma’s Xh-S004 Drug Earns $645 Million Overseas Licensing
August 12, 2025
On August 11, Fosun Pharma announced that its subsidiary Fosun Pharma Industrial has signed a License Agreement with Expedition Therapeutics Inc. to grant Expedition the rights to